# Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL

> **NCT03373071** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bambino Gesù Hospital and Research Institute** · enrollment: 29 (actual)

## Conditions studied

- CD19-ALL
- CD19-LNH

## Interventions

- **BIOLOGICAL:** CD19-CAR T cell

## Key facts

- **NCT ID:** NCT03373071
- **Lead sponsor:** Bambino Gesù Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-23
- **Primary completion:** 2021-05-11
- **Final completion:** 2025-01-24
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03373071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03373071, "Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03373071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*